The blood coagulation system as a molecular machine

Abstract

The human blood coagulation system comprises a series of linked glycoproteins that upon activation induce the generation of downstream enzymes ultimately forming fibrin. This process is primarily important to arrest bleeding (hemostasis). Hemostasis is a typical example of a molecular machine, where the assembly of substrates, enzymes, protein cofactors and calcium ions on a phospholipid surface markedly accelerates the rate of coagulation. Excess, pathological, coagulation activity occurs in “thrombosis”, the formation of an intravascular clot, which in the most dramatic form precipitates in the microvasculature as disseminated intravascular coagulation. Thrombosis occurs according to a biochemical machine model in the case of atherothrombosis on a ruptured atherosclerotic plaque, but may develop at a slower rate in venous thrombosis, illustrating that the coagulation machinery can act at different velocities. The separate coagulation enzymes are also important in other biological processes, including inflammation for which the rapid conversion of one coagulation factor by the other is not a prerequisite. The latter role of coagulation enzymes may be related to the old and probably maintained function of the coagulation machine in innate immunity. BioEssays 25:1220–1228, 2003. © 2003 Wiley Perioicals, Inc.

MECHANISMS IN ENDOCRINOLOGY: The spectrum of haemostatic abnormalities in glucocorticoid excess and defect

“…The haemostatic-coagulation system is the first line of defence against trauma, and it is finely tuned to prevent excessive bleeding or thrombosis (1). It is a complex but highly regulated system designed to stabilise the free flow of blood and blood constituents while also preserving the integrity of the vasculature.…”

Carbon Monoxide-Induced Early Thrombolysis Contributes to Heme Oxygenase-1-Mediated Inhibition of Neointimal Growth after Vascular Injury in Hypercholesterolemic Mice

“…It is a complex process influenced by coagulation and fibrinolytic pathways [9,10], inflammation [11], and hypercholesterolemic state [12]. The first line of evidence supporting the anti-thrombotic effect of HO-1 in vivo is the observation that CO suppressed vascular thrombosis occurring during the cardiac graft rejection likely through inhibiting platelet aggregation [13].…”

Endothelial Activation in Lacunar Stroke Subtypes

“…By binding to activated factor VIIa, TF initiates the extrinsic coagulation pathway. 12 Thrombomodulin (TM) is normally expressed on the endothelial cell surface, where it mediates the activation of the anticoagulant protein C. 13 Tissue plasminogen activator (tPA) converts plasminogen to plasmin, which lyses clots. 14 The activity of tPA is inhibited by binding to plasminogen activator inhibitor type 1 (PAI-1), which is also constitutively secreted by the endothelium.…”